Poxel SA (POXEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Poxel SA (POXEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14819
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate carrier, and PXL770, an adenosine monophosphate-activated protein kinase, for non-alcoholic steatohepatitis (NASH) and metabolic diseases; and PXL007, for hepatitis B. Poxel is also developing earlier-stage programs, which includes deuterated drug candidates for the treatment of metabolic, specialty and rare diseases. It works in partnership with Sumitomo Dainippon Pharma, DeuteRx LLC and Roivant Sciences to research and develop products for metabolic disorders. The company is a spin-off from Merck Serono. Poxel is headquartered in Lyon, France.

Poxel SA Key Recent Developments

Feb 12,2019: Poxel announces fourth quarter and full year 2018 financial update
Nov 26,2018: Poxel Announces Initiation of Part 2 of Phase 1a Study for PXL065, which is being Developed for the Treatment of NASH
Nov 12,2018: Poxel Presents Promising Data for PXL770 and PXL065 for the Treatment of NASH at the American Association for the Study of Liver Diseases Meeting
Oct 16,2018: Poxel reports third quarter and nine months 2018 financial update
Oct 08,2018: Poxel Announces Completion of Patient Enrollment for TIMES 2 Trial in Phase 3 Registration Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan

This comprehensive SWOT profile of Poxel SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Poxel SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Poxel SA – Key Information
Poxel SA – Overview
Poxel SA – Key Employees
Poxel SA – Key Employee Biographies
Poxel SA – Key Operational Heads
Poxel SA – Major Products and Services
Poxel SA – History
Poxel SA – Company Statement
Poxel SA – Locations And Subsidiaries
Poxel SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Poxel SA – Business Description
Poxel SA – Corporate Strategy
Poxel SA – SWOT Analysis
SWOT Analysis – Overview
Poxel SA – Strengths
Poxel SA – Weaknesses
Poxel SA – Opportunities
Poxel SA – Threats
Poxel SA – Key Competitors

Section 3 – Company Financial Performance Charts

Poxel SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Poxel SA, Key Information
Poxel SA, Key Ratios
Poxel SA, Share Data
Poxel SA, Major Products and Services
Poxel SA, History
Poxel SA, Key Employees
Poxel SA, Key Employee Biographies
Poxel SA, Key Operational Heads
Poxel SA, Other Locations
Poxel SA, Subsidiaries
Poxel SA, Key Manufacturing facilities
Poxel SA, Key Competitors
Poxel SA, SWOT Analysis
Poxel SA, Ratios based on current share price
Poxel SA, Annual Ratios
Poxel SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Poxel SA, Performance Chart
Poxel SA, Ratio Charts

★海外企業調査レポート[Poxel SA (POXEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baxter International Inc (BAX):企業の財務・戦略的SWOT分析
    Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Viasat Inc
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • HD Supply, Inc. (HDS):企業の財務・戦略的SWOT分析
    HD Supply, Inc. (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Trinity Biotech Plc (TRIB)-医療機器分野:企業M&A・提携分析
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • British Broadcasting Corporation:企業の戦略・SWOT・財務情報
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Gerdau S.A.:戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Chugach Electric Association, Inc.:発電所・企業SWOT分析
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Invion Ltd (IVX)-製薬・医療分野:企業M&A・提携分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta blocker for inflammatory …
  • CIRCOR Aerospace Products Group:企業の戦略・SWOT・財務情報
    CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report Summary CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sri Lanka Telecom PLC (SLTL.N0000):企業の財務・戦略的SWOT分析
    Sri Lanka Telecom PLC (SLTL.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Divergent Energy Services Corp (DVG):石油・ガス:M&Aディール及び事業提携情報
    Summary Divergent Energy Services Corp (Divergent Energy), formerly CDN Oilfield Technologies and Solutions Corp is an energy service company that offers artificial lift technologies for the oil and gas industry. The company offers products such as electromagnetic submersible pumps and electric subm …
  • Old Mutual Plc:戦略・SWOT・企業財務分析
    Old Mutual Plc - Strategy, SWOT and Corporate Finance Report Summary Old Mutual Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tampa Electric Co:企業の発電所・SWOT分析2018
    Tampa Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • Sunningdale Tech Ltd (BHQ):企業の財務・戦略的SWOT分析
    Summary Sunningdale Tech Ltd (Sunningdale) is a chemical company that manufactures and markets tooling and plastic injection moulding components. The company's plastic solutions include product and mould designs, injection moulding, mould fabrication, complementary finishings, and precision assembly …
  • Orliman SLU-医療機器分野:企業M&A・提携分析
    Summary Orliman SLU (Orliman), a subsidiary of The Riverside Company is a medical device company that develops and manufactures orthopedic products. The company's products include stabilizers, immobilizers, lumbosacral back supports, abdominal bands, abdominal belt, shoulder supports, truss, corsets …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆